Brief 15 minute presentations from companies developing peptide therapeutics and related technologies. This rapid and compressed format is designed for quick introduction between symposium participants to new technologies, and companies. Each presentation is structured to highlight the value of the technology or therapeutic being offered and the business strategy.
M. Karen Newell-Rogers
Professor/Consultant
VG Life Sciences/Texas A&M Health Sciences Center
Ken Cundy
Chief Scientific Officer
CohBar, Inc.
Nozer Mehta
Vice President, Biologics
MonoSol Rx
Michael Sekar
Sr. Director, Formulation Research
Durect Corporation
Maja Kohn
Principal Investigator
European Molecular Biology Laboratory
Debbie Eckert
Scientific Director, D-Peptide Research Division
Navigen, Inc.
Todd Camenisch
CEO and Scientist
Arizona Cancer Therapeutics
Ashok Bhandari
Senior Director, Chemistry
Protagonist Therapeutics
Heidi Wilson
Assistant Professor
Claudin Technologies and University of Colorado Denver -Anschutz Medical Campus
Kenneth Gruber
President/Chief Scientific Officer
Tensive Controls, Inc.
Richard Hopkins
Director
Phylogica
Updates on clinical development of peptide therapeutics.
Elizabeth Mittendorf
Associate Professor, Deputy Chair Research, Department of Surgical Oncology
The University of Texas MD Anderson Cancer Center
Warren Joseph
Consultant, Lower Extremity Infectious Diseasess
Roxborough Memorial Hospital, Philadelphia, PA
Jerome Connor
Vice President of Research and Development
Cerapedics Inc
Deborah O'Neil
Chief Executive & Scientific Officer
NovaBiotics Ltd
Jamal Temsamani
Director of Drug Development
Vect Horus
Novel approaches to peptide drug delivery including devices, molecular engineering, conjugation, and formulation technologies
Bobby Singh
CTO
Corium International, Inc.
Jim Ballance
VP Research & Scientific Affairs
PhaseBio Pharmaceuticals, Inc.
Bruce Littman
CEO
Portage Pharmaceuticals LTD
Francesca Milletti
Principal Scientist
Roche
